GC LabCell Taps Alliances In Bid For Lead NK Cell Position
Links With Artiva In US
After accumulating technologies to develop off-the-shelf, allogeneic NK cell therapies over the past decade, Korea's GC LabCell is now tapping into the global market as US partner Artiva begins clinical trials of its lead asset.
